NEW HAVEN, Conn.--(BUSINESS WIRE)--Rallybio Corporation (Nasdaq: RLYB), a clinical-stage biotechnology company translating scientific advances into transformative therapies for patients with ...

DURHAM, N.C.--(BUSINESS WIRE)--Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS ® platform to develop in vivo gene editing ...

Coya Therapeutics, Inc. (NASDAQ: COYA) ("Coya" or the "Company"), a clinical-stage biotechnology company focused on developing biologics that enhance regulatory T cell (Treg) function in patients with ...

SHELTON, CT / ACCESS Newswire / May 8, 2025 / NanoViricides, Inc. (NNVC) (NYSE Amer.:NNVC) (the "Company") today reported that it has received approval from the National Ethics Committee for Health ...

Calgary, Alberta, September 4, 2025 –TheNewswire -Universal Ibogaine Inc. (IBO:CA) (TSXV: IBO, in USA: IBOGF, in Germany FSE:JC4) (“UI” or the “Company) is pleased to announce its intention to file, ...

Wave Life Sciences announced WVE-007, an siRNA treatment for obesity aimed at silencing INHBE to promote sustainable weight loss. Wave Life Sciences has announced the submission of a clinical trial ...

- Final clinical candidate safety data and plans for the Phase 1 trial to be shared in November prior to the American Association for the Study of Liver Diseases meeting DURHAM, N.C.--(BUSINESS WIRE)- ...

A logjam of clinical trial applications that has bult up at the U.K. Medicines and Healthcare products Agency (MHRA) is deterring companies from conducting studies in the U.K., according to the ...

The EMA will require all new clinical trial applications to be submitted via its clinical trials information system after Jan. 31, 2023, despite pharma companies and other users raising concerns about ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has announced proposals to "streamline" clinical trial approvals, in what it called "the biggest overhaul of trial regulation in 20 years ...